Source: France Soir

Belgian study on hydroxychloroquine has just been published, on 8,000 patients, and concludes that hydroxychloroquine reduces mortality by 30%, like the Italian study mentioned in our article of August 4, 2020.

The results are edifying and it is surprising that the Scientific Council, the Ministry of Health and the French media do not talk about it more.

Hydroxychloroquine has shown a decrease in mortality from COVID-19, in a proportion of patients similar to that seen in the Italian study, according to a Belgian national analysis published today in the International Journal of Antimicrobial Agents. 

The study is retrospective and of course has several limitations. However, associated with the Iacoviello study, it is starting to build up an important core of data on a large number of patients. 

The effects of hydroxychloroquine are of course limited because, after decades of HIV / AIDS research, the use of a single drug cannot be considered a definitive solution for an illness caused by an RNA virus. Combinations of drugs are needed. 

In this regard, another study published today by the same journal showed the additive effects of azithromycin to a combination of hydroxychloroquine and an HIV protease inhibitor, thus confirming Raoult’s studies. 

Combinations of hydroxychloroquine and the HIV protease inhibitor lopinavir / r are recommended by Chinese guidelines for COVID-19 treatment but have been largely ignored by Western countries, with the exception of Italy, where this association was first encouraged in the guidelines last February but then discouraged by the Italian drug regulatory agency for rather mysterious reasons. Dr. Savarino will express his thoughts on this subject, as they were first recommended in the guidelines of last February, but then discouraged by the Italian Medicines Regulatory Agency (AIFA) for reasons which remain unexplained to date.


France Study: Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time

The Coronavirus Is Man Made According to Luc Montagnier the Man Who Discovered HIV

France Soir: Oxford, Recovery and Solidarity – Overdosage in two clinical trials with acts considered criminal?

Screening, hydroxychloroquine… Professor Raoult’s criticisms of the management of the health crisis

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »

How Dr. Paul Marik Saved a Grandmother & The World (Part 3)

Recently Merck issued a stern warning that seemed written by marketing, Kory says, “as it had no scientific data to support the conclusion,” that ivermectin was suddenly dangerous. Another pharmaceutical company’s CEO privately noted that “People must think Merck knows what they’re talking about because it’s their drug,” but Merck has “tremendous disincentives” to say nice things about the generic pill, as it has already spent hundreds of millions of dollars developing an oral anti-viral COVID-19 treatment, rival to ivermectin, that may be priced at $3,000 a dose.

Read More »

How Dr. Paul Marik Saved a Grandmother & The World (Part 2)

They also restricted the use of essential off-label and generic drugs with blatant disinformation campaigns that reminded Kory of big tobacco’s efforts to hide the dangers of smoking. In effect, the public health authorities eliminated the full toolbox of essential scientific methods and drugs that doctors use every day, including the most effective early, prophylactic, and late-stage treatments for COVID-19, which were developed by frontline doctors, not pharmaceutical companies.

Read More »

How Dr. Paul Marik Saved a Grandmother & The World (Part I)

In the professor’s continual review of “the latest (and best) literature,” he picked up a surprising “data signal” in October from emerging studies in Latin America. ivermectin, a safe, cheap, FDA-approved anti-parasitic drug, was showing remarkable anti-viral and anti-inflammatory activity as a repurposed drug—the most powerful COVID-19 killer known to science. 

Read More »